Gyroscope Therapeutics
Gyroscope Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, since acquired, 3 tracked investors.
About Gyroscope Therapeutics
Based in the United Kingdom, Gyroscope Therapeutics is a startup founded in 2010. Gyroscope Therapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing gene therapies for eye diseases, particularly geographic atrophy secondary to age-related macular degeneration (AMD). Its lead investigational therapy, GT005, aims to restore balance to an overactive complement system within the eye.
Explore Gyroscope Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.